NYSE:ELMD Electromed (ELMD) Stock Price, News & Analysis $41.22 -1.32 (-3.10%) Closing price 08/14/2026 04:00 PM EasternExtended Trading$41.34 +0.12 (+0.29%) As of 08/14/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Electromed Stock (NYSE:ELMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Electromed alerts:Sign Up Key Stats Today's Range$40.92▼$43.2250-Day Range$36.29▼$46.3152-Week Range$18.81▼$47.40Volume58,684 shsAverage Volume72,152 shsMarket Capitalization$341.30 millionP/E Ratio54.96Dividend YieldN/APrice Target$37.50Consensus RatingModerate Buy Company Overview Electromed Inc. (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients. The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components. Electromed produces private-label and branded items that meet or exceed industry quality standards, supplying home healthcare providers, sleep clinics and respiratory therapists. Its integrated manufacturing processes—from material sourcing to final assembly—aim to ensure product consistency, quick turnaround times and cost efficiencies for its customers. Founded in 2003 and headquartered in Jacksonville, Florida, Electromed operates manufacturing and distribution facilities within the United States and maintains a growing international customer base. The company’s vertically integrated operations and emphasis on research and development support ongoing product innovation and regulatory compliance. Electromed’s management team draws on decades of experience in the medical device sector to guide strategic growth and expand market reach.AI Generated. May Contain Errors. Read More Electromed Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks24th Percentile Overall ScoreELMD MarketRank™: Electromed scored higher than 24% of companies evaluated by MarketBeat, and ranked 834th out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingModerate Buy Consensus RatingElectromed has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and no sell ratings.Downside RiskElectromed has a consensus price target of $37.50, representing about 9.0% downside from its current price of $41.22.Amount of Analyst CoverageElectromed has only been the subject of 1 research reports in the past 90 days.Read more about Electromed's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Electromed is 54.96, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 45.63.Price to Earnings Ratio vs. SectorThe P/E ratio of Electromed is 54.96, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.26.Price to Book Value per Share RatioElectromed has a P/B Ratio of 8.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ELMD. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldElectromed does not currently pay a dividend.Dividend GrowthElectromed does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.77 News SentimentElectromed has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Electromed this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for ELMD on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows1 people have added Electromed to their MarketBeat watchlist in the last 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Electromed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $783,016.00 in company stock.Percentage Held by Insiders10.50% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions40.82% of the stock of Electromed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Electromed's insider trading history. Receive ELMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELMD Stock News HeadlinesElectromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026August 11, 2026 | businesswire.comElectromed: Strong Margins, Strong Growth, Large RunwayJune 13, 2026 | seekingalpha.comThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.August 16 at 1:00 AM | Porter & Company (Ad)Electromed Inc (ELMD) Q3 2026 Earnings Call Highlights: Record Revenue Growth and Strategic ...May 13, 2026 | finance.yahoo.comElectromed, Inc. (ELMD) Q3 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comElectromed Reports Record Q3 Revenue and Profit GrowthMay 12, 2026 | tipranks.comElectromed, Inc. Announces Record Financial Performance in Fiscal 2026 Third QuarterMay 12, 2026 | businesswire.comElectromed Inc (ELMD) Q3 2026 Earnings Report Preview: What To Look ForMay 11, 2026 | finance.yahoo.comSee More Headlines ELMD Stock Analysis - Frequently Asked Questions How have ELMD shares performed this year? Electromed's stock was trading at $29.12 at the start of the year. Since then, ELMD stock has increased by 41.6% and is now trading at $41.22. How were Electromed's earnings last quarter? Electromed, Inc. (NYSE:ELMD) posted its quarterly earnings data on Tuesday, November, 12th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.03 by $0.13. The firm had revenue of $14.67 million for the quarter. Electromed had a trailing twelve-month return on equity of 15.71% and a net margin of 11.34%. How will Electromed's stock buyback program work? Electromed's board approved a stock repurchase program on Monday, March 10th 2025, which authorizes the company to repurchase $5,000,000 in shares, according to EventVestor. This means that the company could purchase up to 2.4% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's management believes its stock is undervalued. When did Electromed IPO? Electromed (ELMD) raised $10 million in an initial public offering on the week of October 3rd 2011. The company issued 2,000,000 shares at $4.00-$6.00 per share. Who are Electromed's major shareholders? Electromed's top institutional investors include BlackRock Inc. (5.62%), Bank of New York Mellon Corp (0.56%), Man Group plc (0.46%) and Globeflex Capital L P (0.43%). Insiders that own company stock include James L Cunniff, Bradley M Nagel and Andrew Summers. View institutional ownership trends. How do I buy shares of Electromed? Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Electromed own? Based on aggregate information from My MarketBeat watchlists, some other companies that Electromed investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), Meta Platforms (META), Pfizer (PFE), TransEnterix (TRXDW) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings11/12/2024Today8/16/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 ELMD's financial health is in the Green zone, according to TradeSmith. ELMD has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:ELMD CIK1488917 Websmartvest.com Phone(952) 758-9299Fax866-758-5077Employees160Year Founded1992Price Target and Rating Average Price Target for Electromed$37.50 High Price Target$40.00 Low Price Target$36.00 Potential Upside/Downside-9.0%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$1.17 Trailing P/E Ratio54.96 Forward P/E RatioN/A P/E GrowthN/ANet Income$5.15 million Net Margins11.34% Pretax Margin15.57% Return on Equity15.71% Return on Assets13.37% Debt Debt-to-Equity RatioN/A Current Ratio5.10 Quick Ratio4.74 Sales & Book Value Annual Sales$71.75 million Price / Sales4.76 Cash Flow$1.00 per share Price / Cash Flow41.36 Book Value$5.10 per share Price / Book8.08Miscellaneous Outstanding Shares8,280,000Free Float7,359,000Market Cap$341.30 million OptionableOptionable Beta0.51 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSE:ELMD) was last updated on 8/16/2026 by MarketBeat.com Staff. From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredBarricks gold output fell from 2 million ounces to 719000Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...Golden Portfolio | SponsoredNvidia's CEO says this small device is critical for AI growthA tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it esse...Brownstone Research | SponsoredRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
